Surveillance of Suspected Adverse Reactions to Natural Health Products: The Case of Propolis

Authors: Menniti-Ippolito, Francesca1; Mazzanti, Gabriela2; Vitalone, Annabella2; Firenzuoli, Fabio3; Santuccio, Carmela4

Source: Drug Safety, Volume 31, Number 5, 2008 , pp. 419-423(5)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Natural health products are promoted to the public as equally or more effective and less toxic than conventional drugs. However, some `natural' medicines are known to have adverse effects.

From April 2002 to August 2007, 18 suspected adverse reactions associated with propolis-containing products were reported to the national surveillance system of natural health products, coordinated by the Italian National Health Institute. Sixteen reports concerned allergic reactions (with dermatological or respiratory symptoms), while two concerned the digestive tract. Some of the reactions were serious: six patients were admitted to hospital or visited an emergency department and in two of these a life-threatening event was reported. In seven patients (four of whom were children), an allergic predisposition was indicated.

Propolis, a resinous substance collected by honeybees from the buds of living plants, has been used for several purposes (dermatitis, laryngitis, oral ulcers) because of its wide range of suggested activities (antibacterial, antiviral, antifungal, anti-inflammatory, antioxidant and chemopreventive actions). However, propolis is also a potent sensitizer and should not be used in patients with an allergic predisposition, in particular an allergy to pollen.

In Italy, products containing bee derivatives (bee pollen, royal jelly or propolis) are available to the public as food supplements. No label warning of possible adverse reactions is found on the packaging, although it is well known that atopic and asthmatic individuals may be at an increased risk of allergic reactions after using these products. The public and healthcare practitioners should be aware of the risk of allergic reactions to products derived from bees and a warning should be added to the packaging of these products.

Keywords: Adverse reaction monitoring; Herbal medicines; Pharmacovigilance; Propolis

Document Type: Research article

Affiliations: 1: 1 National Centre for Epidemiology, National Institute of Health, Rome, Italy 2: 2 Department of Human Physiology and Pharmacology, University “La Sapienza”, Rome, Italy 3: 3 Centre for Natural Medicine, S. Giuseppe Hospital, Empoli, Italy 4: 4 Pharmacovigilance Unit, Italian Medicines Agency, Rome, Italy

The full text article is available for purchase

$54.95 plus tax

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A